Wednesday, January 13, 2021
10:25 AM EST – Numinus Wellness Inc. : Announced it has acquired the Orbitrap Exploris 120 mass spectrometer with Vanquish Flex Binary instrument for its continued research and development of Psilocybe mushroom related projects at Numinus Bioscience, the Company’s 7,000 square foot analytics and research laboratory. Implementation of the Orbitrap, a state-of-the-art high resolution mass spectrometry instrument, will continue the accelerated trajectory of Numinus Bioscience’s research strategy to optimize cultivation, harvest, and extraction of Psilocybe mushrooms. This follows Numinus’ successful completion of the first legal extraction in Canada by a public company for research and development purposes in December. Numinus Wellness Inc. (V.NUMI) shares were off 6 cents at 1.12.
Stocks in Play: Numinus Wellness Inc., Wed, 13 Jan 2021 10:30:02 EST